High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis
A Randomized Control Trial Of High-Dose Isoniazid Adjuvant Therapy For Multidrug Resistant Tuberculosis
Sponsor: GSVM Medical College
This PHASE2/PHASE3 trial investigates Tuberculosis, Multidrug-Resistant and is currently completed. GSVM Medical College leads this study, which shows 4 recorded versions since 2004 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
First recorded
Jan 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GSVM Medical College
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.